Understanding tamoxifen's confounding effects in Cre-loxP mouse models and strategies for more rigorous genetic research.
Discover how genetic variations in CYP2D6, CYP3A5, SULT1A1 and UGT2B15 enzymes determine tamoxifen effectiveness in breast cancer treatment through pharmacogenetics.